GAITHERSBURG, MD--(Marketwired - May 6, 2013) - Cytomedix, Inc. (OTCQX: CMXI), a regenerative therapies company commercializing and developing innovative platelet and adult stem cell technologies, announced today that the Company will release financial results for the three-month period ended March 31, 2013, after the close of the market on Thursday, May 9, 2013.
Martin Rosendale, Chief Executive Officer, will host a conference call beginning at 8:00am Eastern time on Friday, May 10, 2013 to discuss the first quarter results and to answer questions,
I've been buying some shares with an ave. price of .51. The q3 report is the one i'm really interested in hearing. Hopefully Martin can shake some fear out of people for the q1 report. We will see come Friday morning.
Does anyone really think that anything good will come out of the company on Friday?? Look at the health of the stock people! It's going down, down, down... the only thing uncertain is whether it will go to .25 or not! Wake up people!